Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023205 · ClinicalTrials.gov registry record · Phase 2
Impact of Literacy Level on Patient Education and Health Among People With Arthritis
A Phase 2 study of Rheumatoid Arthritis and Psoriatic Arthritis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT00023205: Completed Phase 2 study of Rheumatoid Arthritis and Psoriatic Arthritis, sponsored by Brigham and Women's Hospital.
NCT00023205 is a Phase 2 study of Rheumatoid Arthritis and Psoriatic Arthritis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 134 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023205, a Phase 2 study of Rheumatoid Arthritis and Psoriatic Arthritis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
People with poor literacy may have worse health and less knowledge about how to manage their disease than patients at high reading levels. Patients with arthritis usually receive information on how to manage their disease that is written at an 11th grade reading level. The purpose of this study is to compare the health outcomes of patients with arthritis given either standard 11th grade level materials or interactive, in-person arthritis education along with materials written at a lower reading level.
Primary Outcome
self report of medication use on standard form
Conditions Studied
Interventions
- BEHAVIORAL 11th grade reading level arthritis materials
- BEHAVIORAL Interactive in-person arthritis education
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00023205 record still lists
NCT00023205 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which 11th grade reading level arthritis materials is the first listed.
NCT00023205 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00023205 about?
NCT00023205 is a clinical study titled "Impact of Literacy Level on Patient Education and Health Among People With Arthritis". People with poor literacy may have worse health and less knowledge about how to manage their disease than patients at high reading levels. Patients with arthritis usually receive information on how to manage their disease that is written at an 11th grade reading level. The purpose of this study is t...
What is the current status of trial NCT00023205?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 134 participants. The study started on 2002-11. Estimated completion is 2006-12.
What conditions does trial NCT00023205 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Polyarthritis.
What interventions are being tested in trial NCT00023205?
The interventions under investigation include: 11th grade reading level arthritis materials (BEHAVIORAL), Interactive in-person arthritis education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00023205?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00023205 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00023205's enrollment target sits among peer trials
134 105th of 197 higher than 93 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of SPY072 in Rheumatic Disease
RECRUITING · Phase 2
-
Dynamic Treatment Regiments for Glucocorticoid Tapering
RECRUITING · Phase 2
-
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 2
-
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
RECRUITING · Phase 2
-
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia